Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of August 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on August 14, 2018. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 and includes a press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The text consists solely of the cover page, signature block, and exhibit index.
Material Changes
The filing text does not provide information regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided content.
Guidance, Outlook, and Risks
The document does not contain management commentary, guidance, outlook, risk factors, contingencies, or descriptions of unusual items. The content is limited to administrative filing details and the reference to an attached press release, the text of which is not included in the input.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Press Release) to obtain the actual financial results or material events for August 2018.
- Confirm the identity of the registrant, as the input metadata mentions "Akso Health Group" while the filing text explicitly names "Hexindai Inc."
- Review the full Form 20-F annual report for comprehensive financial statements, as this Form 6-K does not include them.